Clinical trial
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination…
NCT00090103 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00090103 |
|---|---|
| Title | Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment |
| Official title | A Randomized, Double-blind, Parallel Group Study to Investigate the Efficacy and Safety of Treatment With Dutasteride (0.5mg) and Tamsulosin (0.4mg), Administered Once Daily for 4 Years, Alone and Combination, on the Improvement of Symptoms and Clinical Outcome in Men With Moderate to Severe… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | dutasteride 0.5mg once daily for 4 years, tamsulosin 0.4mg once daily for 4 years |
| Enrollment | 4,844 |
| Start date | Nov 1, 2003 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Aug 26, 2004 |
| Last update posted | Feb 28, 2017 |
| Countries | Argentina, Belgium, Brazil, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, France, Germany, Greece and 24 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: